HCMed Innovations(HCMedi), a professional firm in the respiratory field, will be exhibiting and sponsoring RDD Europe 2017 (Respiratory Drug Delivery), to create the future of inhalation therapy with you.
Come and visit HCMedi's table for our latest breakthrough. The deeproTM drug delivery platform is now equipped with new feature, breath-actuation. Combining the MD self-steering Technology and breath-actuation, deeproTM synchronizes stable aerosol output with breathing pattern to enhance treatment efficacy.
Bring your idea to our table 33 atRDD Europe 2017, and see how we could construct the bright future of inhalation therapy together.